SCHEMBL7076583

SCHEMBL7076583

COC(=O)c1ccsc1-c1cccc(OCCN(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 4/20 0.48
LMNA P02545 1/20 0.48
CHRNB2 P17787 2/20 0.48
CHRNA4 P43681 2/20 0.48
DYRK3 O43781 1/20 0.46
MAP4K4 O95819 1/20 0.46
PIM1 P11309 1/20 0.46
RPS6KB1 P23443 1/20 0.46
CSNK2A1 P68400 1/20 0.46
PKN2 Q16513 1/20 0.46
PIM3 Q86V86 1/20 0.46
BRSK1 Q8TDC3 1/20 0.46
AURKB Q96GD4 1/20 0.46
HIPK2 Q9H2X6 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
STK17A Q9UEE5 1/20 0.46
MAP4K5 Q9Y4K4 1/20 0.46
HCRTR1 O43613 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076016 0.94 KDM4E (0.49) KDM4EALDH1A1LMNACHRNB2CHRNA4
SCHEMBL7136554 0.93 ALDH1A1 (0.50) KDM4EALDH1A1LMNACHRNB2CHRNA4
SCHEMBL7131687 0.88 KDM4E (0.53) KDM4EALDH1A1LMNACHRNB2CHRNA4
SCHEMBL7130108 0.86 KDM4E (0.43) KDM4EALDH1A1LMNATDP1L3MBTL1
SCHEMBL7075715 0.86 KDM4E (0.43) KDM4EALDH1A1LMNATDP1L3MBTL1
SCHEMBL7074931 0.84 KDM4E (0.44) KDM4EALDH1A1LMNATDP1L3MBTL1
SCHEMBL7076243 0.82 KDM4E (0.54) KDM4EALDH1A1LMNACHRNB2CHRNA4
SCHEMBL7075963 0.81 ALDH1A1 (0.55) KDM4EALDH1A1LMNAESR1SMN1; SMN2
SCHEMBL1776033 0.81 KDM4E (0.53) KDM4EALDH1A1LMNACHRNB2CHRNA4
SCHEMBL7135585 0.79 BACE1 (0.56) KDM4EALDH1A1ESR1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051368-A1 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-06-26 WO disclosed